151
Participants
Start Date
September 25, 2009
Primary Completion Date
June 22, 2011
Study Completion Date
June 22, 2011
Icatibant
Single subcutaneous injection of icatibant, 30 mg
Universitätsklinik für Dermatologie und Venerologie, Graz
Universitätsspital Zürich / Dermatologische Klinik, Zurich
Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, Charité, Berlin
Ospedale Luigi Sacco, Milan
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario La Paz, Servicio de Alergia, Madrid
Bnai-Zion M.C. Clinical Immunology and Allergy Division, Haifa
Clinique Universitaire de Medicine/ Centre National de reference, Grenoble
Universitäts-Hals-Nasen-Ohren-Klinik Essen, Universität Duisburg-Essen, Essen
Hospital Universitario La Fe, Servicio de Alergia, Valencia
Centre Hospitalier Universitaire/ Service de Dermatologie, Angers
The Chaim Sheba Medical Center, The Allergy and Clinical Immunology Unit, Tel Litwinsky
Hautklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität, Mainz
Hopital Claude Huriex/ Service de medicine interne, Lille
Klinkum der Johann Wolfgang Goethe-Universitat, Frankfurt am Main
Tel Aviv Sourasky Medical Center - Allergy Unit, Tel Aviv
Hospital Edouaed Herriot, Lyon
Hopital Europeen Georges Pompidou Immunologie Clinique, Paris
Universita degli Studi di Napoli 'Federico II', Napoli
Hospital Britanico Unidad de Alergia, Buenos Aires
Odense Universitetshospital-OUH, Odense
Luzerner Kantonsspital, Lucerne
Hospital Universitario Vall de Hebrón / Sección de Alergia, Escola Infermeria, Barcelona
Southmead Hospital, Department of Immunology, Bristol
Barts & The London NHS Trust, Pathology and Pharmacy Building, London
Derriford Combined Laboratory, Department of Clinical Immunology & Allergy, Plymouth